drugset / Trial / NCT01408849

Use of Maytenus Ilicifolia in the Treatment of Dyspepsia

NCT01408849

RandomizedParallel-groupSingle-blindTreatment

Summary

This study aims to evaluate the therapeutic effect of the infusion of Maytenus ilicifolia Mart. ex Reiss leaves, used for 8 weeks, on patients with dyspepsia. Primary endpoint is SODA score, secondary endpoint is endoscopic classification (Sydney).

Timeline

Start
2015-02
Primary completion
2016-01
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Maytenus ilicifolia Unknown 2 g
Comparator Omeprazole Other / unclassified

Indications